Cargando…

Diagnostic potential of plasma carboxymethyllysine and carboxyethyllysine in multiple sclerosis

BACKGROUND: This study compared the level of advanced glycation end products (AGEs), N-(Carboxymethyl)lysine (CML) and N-(Carboxyethyl)lysine (CEL), in patients with multiple sclerosis (MS) and healthy controls (HCs), correlating these markers with clinical indicators of MS disease severity. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sternberg, Zohara, Hennies, Cassandra, Sternberg, Daniel, Wang, Ping, Kinkel, Peter, Hojnacki, David, Weinstock-Guttmann, Bianca, Munschauer, Frederick
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2984414/ https://www.ncbi.nlm.nih.gov/pubmed/21034482 http://dx.doi.org/10.1186/1742-2094-7-72

Ejemplares similares

Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-β
por: Sternberg, Zohara, et al.
Publicado: (2009)

Content of free and protein‐binding N(ε)‐carboxymethyllysine and N(ε)‐carboxyethyllysine in different parts of braised chicken
por: Zhu, Zongshuai, et al.
Publicado: (2020)

Investigation on the Contents of N(ε)-carboxymethyllysine, N(ε)-carboxyethyllysine, and N-nitrosamines in Commercial Sausages on the Chinese Market
por: Wang, Wenjing, et al.
Publicado: (2023)

Air frying combined with grape seed extract inhibits N(ε)-carboxymethyllysine and N(ε)-carboxyethyllysine by controlling oxidation and glycosylation
por: Zhu, Zongshuai, et al.
Publicado: (2020)

Concentrations of N(6)-Carboxymethyllysine (CML), N(6)-Carboxyethyllysine (CEL), and Soluble Receptor for Advanced Glycation End-Products (sRAGE) Are Increased in Psoriatic Patients
por: Damasiewicz-Bodzek, Aleksandra, et al.
Publicado: (2022)

Plasma Protein Pentosidine and Carboxymethyllysine, Biomarkers for Age-related Macular Degeneration
por: Ni, Jiaqian, et al.
Publicado: (2009)

Chronic cerebrospinal venous insufficiency is not associated with cognitive impairment in multiple sclerosis
por: Benedict, Ralph HB, et al.
Publicado: (2013)

Effect of Nɛ-carboxymethyllysine on oxidative stress and the glutathione system in beta cells
por: Boesten, Daniëlle M.P.H.J., et al.
Publicado: (2014)

Controlled Formation of Carboxymethyllysine in Bone Matrix through Designed Glycation Reaction
por: Sroga, Grażyna E., et al.
Publicado: (2021)

Diabetic nephropathy patients show hyper-responsiveness to N6-carboxymethyllysine
por: Dias, C.G., et al.
Publicado: (2022)

Plasma neuronal specific enolase: a potential stage diagnostic marker in human African trypanosomiasis
por: Sternberg, Jeremy M., et al.
Publicado: (2014)

No association between variations in extracranial venous anatomy and clinical outcomes in multiple sclerosis patients over 5 years
por: Gandhi, Sirin, et al.
Publicado: (2019)

Clinical correlates of chronic cerebrospinal venous insufficiency in multiple sclerosis
por: Weinstock-Guttman, Bianca, et al.
Publicado: (2012)

Family Perspectives on Clinical Research for Pediatric Multiple Sclerosis: Enhancing Equity
por: Mandel, Leslie A, et al.
Publicado: (2021)

Serum Hepcidin Levels, Iron Dyshomeostasis and Cognitive Loss in Alzheimer’s Disease
por: Sternberg, Zohara, et al.
Publicado: (2017)

Effect of Teriflunomide and Dimethyl Fumarate on Cortical Atrophy and Leptomeningeal Inflammation in Multiple Sclerosis: A Retrospective, Observational, Case-Control Pilot Study
por: Zivadinov, Robert, et al.
Publicado: (2019)

Association between carotid diameter and the advanced glycation endproduct N(ε)-Carboxymethyllysine (CML)
por: Baumann, Marcus, et al.
Publicado: (2009)

Factors associated with benign multiple sclerosis in the New York State MS Consortium (NYSMSC)
por: Zivadinov, Robert, et al.
Publicado: (2016)

Baijiu Vinasse Extract Scavenges Glyoxal and Inhibits the Formation of N(ε)-Carboxymethyllysine in Dairy Food
por: Wang, Yuzhen, et al.
Publicado: (2019)

Inter- and Intraindividual Differences in the Capacity of the Human Intestinal Microbiome in Fecal Slurries to Metabolize Fructoselysine and Carboxymethyllysine
por: van Dongen, Katja C. W., et al.
Publicado: (2022)

Blood pressure normalization post-jugular venous balloon angioplasty
por: Sternberg, Zohara, et al.
Publicado: (2013)

COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections
por: Jakimovski, Dejan, et al.
Publicado: (2022)

Laquinimod Therapy in Multiple Sclerosis: A Comprehensive Review
por: Kolb-Sobieraj, Channa, et al.
Publicado: (2014)

A novel monoclonal antibody targeting carboxymethyllysine, an advanced glycation end product in atherosclerosis and pancreatic cancer
por: Wendel, Ulrika, et al.
Publicado: (2018)

Anaerobic Degradation of N-ε-Carboxymethyllysine, a Major Glycation End-Product, by Human Intestinal Bacteria
por: Bui, Thi Phuong Nam, et al.
Publicado: (2019)

Decreased brain venous vasculature visibility on susceptibility-weighted imaging venography in patients with multiple sclerosis is related to chronic cerebrospinal venous insufficiency
por: Zivadinov, Robert, et al.
Publicado: (2011)

Iron deposition and inflammation in multiple sclerosis. Which one comes first?
por: Zivadinov, Robert, et al.
Publicado: (2011)

Reasons for discontinuation of subcutaneous interferon β-1a three times a week among patients with multiple sclerosis: a real-world cohort study
por: Sabidó-Espin, Meritxell, et al.
Publicado: (2017)

Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross-sectional preliminary report
por: Zamboni, Paolo, et al.
Publicado: (2011)

Effect of Treatment with Interferon Beta-1a on Changes in Voxel-Wise Magnetization Transfer Ratio in Normal Appearing Brain Tissue and Lesions of Patients with Relapsing–Remitting Multiple Sclerosis: A 24-Week, Controlled Pilot Study
por: Zivadinov, Robert, et al.
Publicado: (2014)

Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study
por: Chitnis, Tanuja, et al.
Publicado: (2013)

Infections, Vaccines and Autoimmunity: A Multiple Sclerosis Perspective
por: Jakimovski, Dejan, et al.
Publicado: (2020)

Plasma Levels of Free N(Ɛ)-Carboxymethyllysine (CML) after Different Oral Doses of CML in Rats and after the Intake of Different Breakfasts in Humans: Postprandial Plasma Level of sRAGE in Humans
por: Helou, Cynthia, et al.
Publicado: (2022)

Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial
por: Dwyer, Michael G., et al.
Publicado: (2015)

Asymptomatic infection after BNT162b2 mRNA COVID-19 vaccination in multiple sclerosis patient
por: Jakimovski, Dejan, et al.
Publicado: (2021)

Neuroimaging Correlates of Patient-Reported Outcomes in Multiple Sclerosis
por: Jakimovski, Dejan, et al.
Publicado: (2023)

Multiple Sclerosis in Children: Differential Diagnosis, Prognosis, and Disease-Modifying Treatment
por: Jakimovski, Dejan, et al.
Publicado: (2021)

The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to in vivo imaging
por: Guan, Yi, et al.
Publicado: (2019)

Humoral Responses to Diverse Autoimmune Disease-Associated Antigens in Multiple Sclerosis
por: Malyavantham, Kishore, et al.
Publicado: (2015)

Increased contrast enhancing lesion activity in relapsing–remitting multiple sclerosis migraine patients()
por: Graziano, Elliot, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_smf2p1ur03066lgt6nnkqft1hg